These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7599322)

  • 1. Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression.
    Kaneko H; Horiike S; Nakai H; Ueda Y; Nakao M; Hirakawa K; Yokota S; Taniwaki M; Misawa S; Kashima K
    Int J Hematol; 1995 Apr; 61(3):113-6. PubMed ID: 7599322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemias.
    Ludwig L; Janssen JW; Schulz AS; Bartram CR
    Leukemia; 1993 Jul; 7(7):1058-60. PubMed ID: 8321021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia.
    Nakai H; Misawa S; Horiike S; Taniwaki M; Seriu T; Shimazaki C; Fujii H; Maekawa T; Furukawa T; Abe T
    Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.
    Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I
    Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
    Preudhomme C; Vachee A; Quesnel B; Wattel E; Cosson A; Fenaux P
    Leukemia; 1993 Jul; 7(7):1071. PubMed ID: 8321023
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of the von Recklinghausen neurofibromatosis (NF1) gene using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) method.
    Sawada S; Honda M; Niimura M
    J Dermatol; 1994 May; 21(5):294-300. PubMed ID: 8051313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome.
    Misawa S; Horiike S; Kaneko H; Kashima K
    Leukemia; 1997 Apr; 11 Suppl 3():533-5. PubMed ID: 9209448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1.
    Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM
    Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutations in the neurofibromatosis 1 gene in human tumors.
    Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M
    Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of the WT1 gene in myelodysplastic syndromes.
    Hosoya N; Miyagawa K; Mitani K; Yazaki Y; Hirai H
    Jpn J Cancer Res; 1998 Aug; 89(8):821-4. PubMed ID: 9765617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of RASK and the 'FLR exon' of NF1 in sporadic ovarian carcinoma.
    Foulkes WD; Englefield P; Campbell IG
    Eur J Cancer; 1994; 30A(4):528-30. PubMed ID: 8018414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 mutation in advanced stage of primary myelodysplastic syndrome.
    Tang JL; Tien HF; Lin MT; Chen PJ; Chen YC
    Anticancer Res; 1998; 18(5B):3757-61. PubMed ID: 9854490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of neurofibromatosis type 1 gene mutation in juvenile chronic myelogenous leukemia.
    Watanabe I; Horiuchi T; Hatta N; Matsumoto M; Koike K; Kojima S; Ohga S; Fujita S
    Acta Haematol; 1998; 100(1):22-5. PubMed ID: 9691142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1.
    Estivill X; Lázaro C; Casals T; Ravella A
    Hum Genet; 1991 Dec; 88(2):185-8. PubMed ID: 1757093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors.
    Scheurlen WG; Senf L
    Int J Cancer; 1995 Aug; 64(4):234-8. PubMed ID: 7657385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.
    Upadhyaya M; Osborn MJ; Maynard J; Kim MR; Tamanoi F; Cooper DN
    Hum Genet; 1997 Jan; 99(1):88-92. PubMed ID: 9003501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
    Quesnel B; Preudhomme C; Vanrumbeke M; Vachee A; Lai JL; Fenaux P
    Leukemia; 1994 May; 8(5):878-80. PubMed ID: 8182944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A de novo nonsense mutation in exon 28 of the neurofibromatosis type 1 (NF1) gene.
    Shen MH; Upadhyaya M
    Hum Genet; 1993 Oct; 92(4):410-2. PubMed ID: 8225323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis.
    Gómez L; Rubio MP; Martin MT; Vázquez JJ; Idoate M; Pastorfide G; Pestaña A; Seizinger BR; Barnhill RL; Castresana JS
    J Invest Dermatol; 1996 Mar; 106(3):432-6. PubMed ID: 8648172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.